FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Chaman Lal Kaul

Research Profile

Chemicals & Drugs

Concepts & Ideas

Living Beings

Occupations

Chemistry, Pharmaceutical

Disorders

Diabetes Mellitus, Experimental

Procedures

Anatomy

Thoracic Aorta

Co-author Network

Publications

TOP 3
Bhoomi Viswanad; Krishnamoorthy Srinivasan; Chaman Lal Kaul; Poduri Ramarao
Effect of tempol on altered angiotensin II and acetylcholine-mediated vascular responses in thoracic aorta isolated from rats with insulin resistance.
Ramesh Panchagnula; Tripta Bansal; Manthena V S Varma; Chaman Lal Kaul
Co-treatment with grapefruit juice inhibits while chronic administration activates intestinal P-glycoprotein-mediated drug efflux.
Shrutidevi Agrawal; Kanwal Jit Kaur; Inderjit Singh; Shantaram R Bhade; Chaman Lal Kaul; Ramesh Panchagnula
Minimum sample size and sampling time requirements for assessment of rifampicin bioequivalence from FDC formulations.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Chaman Lal Kaul (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2006: Bhoomi Viswanad; Krishnamoorthy Srinivasan; Chaman Lal Kaul; Poduri Ramarao
Effect of tempol on altered angiotensin II and acetylcholine-mediated vascular responses in thoracic aorta isolated from rats with insulin resistance.
Pharmacological research : the official journal of the Italian Pharmacological Society 2006;53(3):209-15.
2005: Ramesh Panchagnula; Tripta Bansal; Manthena V S Varma; Chaman Lal Kaul
Co-treatment with grapefruit juice inhibits while chronic administration activates intestinal P-glycoprotein-mediated drug efflux.
Die Pharmazie 2005;60(12):922-7.
2005: Shrutidevi Agrawal; Kanwal Jit Kaur; Inderjit Singh; Shantaram R Bhade; Chaman Lal Kaul; Ramesh Panchagnula
Minimum sample size and sampling time requirements for assessment of rifampicin bioequivalence from FDC formulations.
The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease 2005;9(11):1273-80.
2005: Yasvanth Ashokraj; Gunjan Kohli; Chaman Lal Kaul; Ramesh Panchagnula
Quality control of anti-tuberculosis FDC formulations in the global market: part II-accelerated stability studies.
The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease 2005;9(11):1266-72.
2005: Krishnamoorthy Srinivasan; Bhoomi Viswanad; Lydia Asrat; Chaman Lal Kaul; Poduri Ramarao
Combination of high-fat diet-fed and low-dose streptozotocin-treated rat: a model for type 2 diabetes and pharmacological screening.
Pharmacological research : the official journal of the Italian Pharmacological Society 2005;52(4):313-20.
2005: Yasvanth Ashokraj; Inderjit Singh; Kanwal Jit Kaur; Gunjan Kohli; Shantaram R Bhade; Manthena V S Varma; Chaman Lal Kaul; Ramesh Panchagnula
Establishment of a reference formulation for bioequivalence assessment of rifampicin-containing FDCs: an essential step towards improving tuberculosis treatment.
The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease 2005;9(7):791-6.
2005: Yasvanth Ashokraj; Inderjit Singh; Kanwal Jit Kaur; Gunjan Kohli; Shantaram R Bhade; Manthena V S Varma; Chaman Lal Kaul; Ramesh Panchagnula
Plasma pooling: utility in expediting bioequivalence assessment of rifampicin-containing fixed-dose combinations.
The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease 2005;9(6):697-9.
2005: swapnil Sonkusare; Krishnamoorthy Srinivasan; Chaman Lal Kaul; Poduri Ramarao
Effect of donepezil and lercanidipine on memory impairment induced by intracerebroventricular streptozotocin in rats.
Life sciences 2005;77(1):1-14.
2005: Srinivas Ghatta; K Srinivasan; Chaman Lal Kaul; Poduri Ramarao
A study on alpha-adrenoceptor mediated contractile responses of high fat diet fed rat thoracic aorta.
Die Pharmazie 2005;60(2):142-6.
2005: Arun Kumar; Chaman Lal Kaul; Poduri Ramarao
AT1 receptors and L-type calcium channels: functional coupling in supersensitivity to angiotensin II in diabetic rats.
Cardiovascular research 2005;65(2):374-86.
2005: Sokindra Kumar; Arun Kumar; Chaman Lal Kaul; Shyam S Sharma
Effects of adenosine and adenosine A2A receptor agonist on motor nerve conduction velocity and nerve blood flow in experimental diabetic neuropathy.
Neurological research 2005;27(1):60-6.
2005: Shrutidevi Agrawal; Kanwal Jit Kaur; Inderjit Singh; Shantaram R Bhade; Chaman Lal Kaul; Ramesh Panchagnula
Determination of rifampicin bioequivalence in a three-drug FDC by WHO and indian protocols: effect of sampling schedule and size.
The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease 2005;9(1):75-80.
2005: Arun Kumar; Chaman Lal Kaul; Poduri Ramarao
Green fluorescent proteins in receptor research: an emerging tool for drug discovery.
Journal of pharmacological and toxicological methods 2005;51(1):1-23.
2005: swapnil Sonkusare; Chaman Lal Kaul; Poduri Ramarao
Dementia of Alzheimer's disease and other neurodegenerative disorders--memantine, a new hope.
Pharmacological research : the official journal of the Italian Pharmacological Society 2005;51(1):1-17.
2004: Anuj Kumar Saini; Arun Kumar; Chaman Lal Kaul; Shyam S Sharma
Acute hyperglycemia attenuates nerve conduction velocity and nerve blood flow in male Sprague-Dawley rats: reversal by adenosine.
Pharmacological research : the official journal of the Italian Pharmacological Society 2004;50(6):593-9.
2004: Arun Kumar; Chaman Lal Kaul; Poduri Ramarao
High glucose concentration augments angiotensin II mediated contraction via AT1 receptors in rat thoracic aorta.
Pharmacological research : the official journal of the Italian Pharmacological Society 2004;50(6):561-8.
2004: Ramesh Panchagnula; Shrutidevi Agrawal; Yasvanth Ashokraj; M Varma; Sateesh Kandavilli; Vivekanand Bhardwaj; S Bedi; I Gulati; Jitendra Parmar; Chaman Lal Kaul; B Blomberg; Bernard Fourie; G Roscigno; R Wire; Richard Laing; P Evans; T Moore
Fixed dose combinations for tuberculosis: Lessons learned from clinical, formulation and regulatory perspective.
Methods and findings in experimental and clinical pharmacology 2004;26(9):703-21.
2004: Arun Kumar; Chaman Lal Kaul; Ramarao Poduri
Tempol augments angiotensin II-induced AT2 receptor-mediated relaxation in diabetic rat thoracic aorta.
Journal of hypertension 2004;22(11):2143-52.
2004: Shyam S Sharma; Shankar Munusamy; Meenakshisundaram Thiyagarajan; Chaman Lal Kaul
Neuroprotective effect of peroxynitrite decomposition catalyst and poly(adenosine diphosphate-ribose) polymerase inhibitor alone and in combination in rats with focal cerebral ischemia.
Journal of neurosurgery 2004;101(4):669-75.
2004: Yasvanth Ashokraj; Shrutidevi Agrawal; Manthena V S Varma; Inderjit Singh; K Gunjan; Kanwal Jit Kaur; Shantaram R Bhade; Chaman Lal Kaul; J M Caudron; J Pinel; Ramesh Panchagnula
Quality control of anti-tuberculosis fixed-dose combination formulations in the global market: an in vitro study.
The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease 2004;8(9):1081-8.
2004: Shrutidevi Agrawal; Inderjit Singh; Kanwal Jit Kaur; Shantaram R Bhade; Chaman Lal Kaul; Ramesh Panchagnula
Bioequivalence trials of rifampicin containing formulations: extrinsic and intrinsic factors in the absorption of rifampicin.
Pharmacological research : the official journal of the Italian Pharmacological Society 2004;50(3):317-27.
2004: Ramesh Panchagnula; Tripta Bansal; Manthena V S Varma; Chaman Lal Kaul
Reversed-phase liquid chromatography with ultraviolet detection for simultaneous quantitation of indinavir and propranolol from ex-vivo rat intestinal permeability studies.
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 2004;806(2):277-82.
2004: Meenakshisundaram Thiyagarajan; Chaman Lal Kaul; Shyam S Sharma
Neuroprotective efficacy and therapeutic time window of peroxynitrite decomposition catalysts in focal cerebral ischemia in rats.
British journal of pharmacology 2004;142(5):899-911.
2004: K Srinivasan; P S Patole; Chaman Lal Kaul; Poduri Ramarao
Reversal of glucose intolerance by by pioglitazone in high fat diet-fed rats.
Methods and findings in experimental and clinical pharmacology 2004;26(5):327-33.
2004: Shrutidevi Agrawal; Inderjit Singh; Kanwal Jit Kaur; Shantaram R Bhade; Chaman Lal Kaul; Ramesh Panchagnula
Comparative bioavailability of rifampicin, isoniazid and pyrazinamide from a four drug fixed dose combination with separate formulations at the same dose levels.
International journal of pharmaceutics 2004;276(1-2):41-9.
2004: Naresh Kumar; Chaman Lal Kaul; Ishrath Ansurudeen; Chinmoy S Dey
Combination of metformin and thiazolidindiones restore insulin signalling in insulin-resistant cultured myotubes.
Life sciences 2004;74(15):1877-88.
2004: Uma Ramachandran; Alka Mital; Prasad Bharatam; Smriti Khanna; Poduri Rama Rao; Krishnamoorthy Srinivasan; Rakesh Kumar; Harmander Pal Singh Chawla; Chaman Lal Kaul; Suryaprakash Raichur; Ranjan Chakrabarti
Studies on some glitazones having pyridine as the linker unit.
Bioorganic & medicinal chemistry 2004;12(4):655-62.
2004: Rajesh Gandhi; Chaman Lal Kaul; Ramesh Panchagnula
Pharmacokinetic evaluation of an azithromycin controlled release dosage form in healthy human volunteers: a single dose study.
International journal of pharmaceutics 2004;270(1-2):1-8.
2004: Dhiraj G Kabra; Meenakshisundaram Thiyagarajan; Chaman Lal Kaul; Shyam S Sharma
Neuroprotective effect of 4-amino-1,8-napthalimide, a poly(ADP ribose) polymerase inhibitor in middle cerebral artery occlusion-induced focal cerebral ischemia in rat.
Brain research bulletin 2004;62(5):425-33.
2004: Meenakshi Jain; Suryanarayana Vangapandu; Sandeep Sachdeva; Savita Singh; Prati Pal Singh; Gopabandhu Jena; Kulbhushan Tikoo; Poduri Ramarao; Chaman Lal Kaul; Rahul Jain
Discovery of a bulky 2-tert-butyl group containing primaquine analogue that exhibits potent blood-schizontocidal antimalarial activities and complete elimination of methemoglobin toxicity.
Journal of medicinal chemistry 2004;47(2):285-7.
2004: Suryanarayana Vangapandu; Sandeep Sachdeva; Meenakshi Jain; Savita Singh; Prati Pal Singh; Chaman Lal Kaul; Rahul Jain
8-Quinolinamines conjugated with amino acids are exhibiting potent blood-schizontocidal antimalarial activities.
Bioorganic & medicinal chemistry 2004;12(1):239-47.
2004: Saurabh Gupta; Chaman Lal Kaul; Shyam S Sharma
Neuroprotective effect of combination of poly (ADP-ribose) polymerase inhibitor and antioxidant in middle cerebral artery occlusion induced focal ischemia in rats.
Neurological research 2004;26(1):103-7.
2003: Ramesh Panchagnula; Shradha Rungta; Pavankumar Sancheti; Shrutidevi Agrawal; Chaman Lal Kaul
In vitro evaluation of food effect on the bioavailability of rifampicin from antituberculosis fixed dose combination formulations.
Farmaco (Società chimica italiana : 1989) 2003;58(11):1099-103.
2003: Suryanarayana Vangapandu; Sandeep Sachdeva; Meenakshi Jain; Savita Singh; Prati Pal Singh; Chaman Lal Kaul; Rahul Jain
8-quinolinamines and their pro prodrug conjugates as potent blood-schizontocidal antimalarial agents.
Bioorganic & medicinal chemistry 2003;11(21):4557-68.
2003: Ramesh Panchagnula; Pavankumar Sancheti; Shradha Rungta; Shrutidevi Agrawal; Chaman Lal Kaul
Evaluation of bioequivalence of isoniazid and pyrazinamide in three and four drugs fixed dose combinations using WHO simplified protocol.
Pharmacological research : the official journal of the Italian Pharmacological Society 2003;48(4):383-7.
2003: Gopabandhu Jena; Kumar V S Nemmani; Chaman Lal Kaul; Poduri Ramarao
Protective effect of a polyherbal formulation (Immu-21) against cyclophosphamide-induced mutagenicity in mice.
Phytotherapy research : PTR 2003;17(4):306-10.
2002: Meenakshisundaram Thiyagarajan; Chaman Lal Kaul; Poduri Ramarao
Enhancement of alpha-adrenoceptor-mediated responses in prostate of testosterone-treated rat.
European journal of pharmacology 2002;453(2-3):335-44.
2002: Shrutidevi Agrawal; Inderjit Singh; Kanwal Jit Kaur; Shantaram R Bhade; Chaman Lal Kaul; Ramesh Panchagnula
Bioequivalence assessment of rifampicin, isoniazid and pyrazinamide in a fixed dose combination of rifampicin, isoniazid, pyrazinamide and ethambutol vs. separate formulations.
International journal of clinical pharmacology and therapeutics 2002;40(10):474-81.
2002: Rajesh Gandhi; Omathanu Pillai; Ramasamy Thilagavathi; Bulusu Gopalakrishnan; Chaman Lal Kaul; Ramesh Panchagnula
Characterization of azithromycin hydrates.
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 2002;16(3):175-84.
2002: Kumar V S Nemmani; Gopabandhu Jena; C S Dey; Chaman Lal Kaul; Poduri Ramarao
Cell proliferation and natural killer cell activity by polyherbal formulation, Immu-21 in mice.
Indian journal of experimental biology 2002;40(3):282-7.
2002: Shrutidevi Agrawal; Kanwal Jit Kaur; Inderjit Singh; Shantaram R Bhade; Chaman Lal Kaul; Ramesh Panchagnula
Assessment of bioequivalence of rifampicin, isoniazid and pyrazinamide in a four drug fixed dose combination with separate formulations at the same dose levels.
International journal of pharmaceutics 2002;233(1-2):169-77.
2002: Srinivas Gullapalli; Krishnamoorthy Gurumoorthy; Chaman Lal Kaul; Poduri Ramarao
Role of L-type Ca2+ channels in attenuated morphine antinociception in streptozotocin-diabetic rats.
European journal of pharmacology 2002;435(2-3):187-94.
2001: Chaman Lal Kaul; Poduri Ramarao
The role of aldose reductase inhibitors in diabetic complications: recent trends.
Methods and findings in experimental and clinical pharmacology 2001;23(8):465-75.
2001: Shrutidevi Agrawal; Chaman Lal Kaul; Ramesh Panchagnula
Bioequivalence of isoniazid in a two drug fixed dose combination and in a single drug dosage form.
Die Pharmazie 2001;56(8):636-9.
2001: S Shastri; J Robert McNeill; Thomas W Wilson; R Poduri; Chaman Lal Kaul; Venkat Gopalakrishnan
Cysteinyl leukotrienes mediate enhanced vasoconstriction to angiotensin II but not endothelin-1 in SHR.
American journal of physiology. Heart and circulatory physiology 2001;281(1):H342-9.
2001: Shrutidevi Agrawal; N S Thomas; Anand Babu Dhanikula; Chaman Lal Kaul; Ramesh Panchagnula
Antituberculosis drugs and new drug development.
Current opinion in pulmonary medicine 2001;7(3):142-7.
2001: Anand Babu Dhanikula; Ramesh Panchagnula; Inderjit Singh; Kanwal Jit Kaur; Chaman Lal Kaul; J S Sekhon
Pharmacokinetic study of paclitaxel as a 3-hour infusion in an Indian population: 135 mg/m2 vs. 175 mg/m2.
Methods and findings in experimental and clinical pharmacology 2001;23(2):93-8.
2000: Ramesh Panchagnula; Shrutidevi Agrawal; Kanwal Jit Kaur; Inderjit Singh; Chaman Lal Kaul
Evaluation of rifampicin bioequivalence in fixed-dose combinations using the WHO/IUATLD recommended protocol.
The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease 2000;4(12):1169-72.
2000: Ramesh Panchagnula; Kanwal Jit Kaur; Inderjit Singh; Chaman Lal Kaul
Bioequivalence of rifampicin when administered as a fixed-dose combined formulation of four drugs versus separate formulations.
Methods and findings in experimental and clinical pharmacology 2000;22(9):689-94.
2000: Rajesh Gandhi; Chaman Lal Kaul; Ramesh Panchagnula
Validated LC method for in-vitro analysis of azithromycin using electrochemical detection.
Journal of pharmaceutical and biomedical analysis 2000;23(6):1073-9.
2000: Chaman Lal Kaul; Poduri Ramarao
Renin release and the sympathetic nervous system.
Drugs of today (Barcelona, Spain : 1998) 2000;36(10):699-713.
1999: Poduri Ramarao; Chaman Lal Kaul
Insulin resistance: current therapeutic approaches.
Drugs of today (Barcelona, Spain : 1998) 1999;35(12):895-911.
1999: Ramesh Panchagnula; Inderjit Singh; Kanwal Jit Kaur; Chaman Lal Kaul
Bioequivalence study of rifampicin in fixed-dose combination of rifampicin and isoniazid vs. separate formulations.
Methods and findings in experimental and clinical pharmacology 1999;21(9):625-8.
1999: Ramesh Panchagnula; Kanwal Jit Kaur; Inderjit Singh; Chaman Lal Kaul
The WHO simplified study protocol in practice: investigation of combined formulations supplied by the WHO.
The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease 1999;3(11 Suppl 3):S336-42; discussion S351-2.
1999: Chaman Lal Kaul
Role of sympathetic nervous system in experimental hypertension and diabetes mellitus.
Clinical and experimental hypertension (New York, N.Y. : 1993) 1999;21(1-2):95-112.
1999: Ramesh Panchagnula; Anurag Sood; N Sharda; Kanwal Jit Kaur; Chaman Lal Kaul
Determination of rifampicin and its main metabolite in plasma and urine in presence of pyrazinamide and isoniazid by HPLC method.
Journal of pharmaceutical and biomedical analysis 1999;18(6):1013-20.